Synonyms: IP2015 | IPED-2015 | IPED2015
Compound class:
Synthetic organic
Comment: The chemical structure for pudafensine was obtained from proposed INN list 130 (Feb. 2024), in which the compound is described as a monoamine reuptake inhibitor. Online information indicates that this is Initiator Pharma's clinical candidate IP2015.
|
|
No information available. |
Summary of Clinical Use |
Pudafensine (IP2015) has been advanced as a clinical candidate for organic erectile dysfunction and neuropathic pain. |
Clinical Trials | |||||
Clinical Trial ID | Title | Type | Source | Comment | References |
NCT05728671 | Bioavailability Study to Compare Liquid vs Two Solid Formulations of IP2015 | Phase 1 Interventional | Initiator Pharma | ||
NCT05181852 | Study to Investigate the Pharmacodynamic Effects of IP2015 in Healthy Male Subjects Using the Intradermal Capsaicin Model | Phase 1 Interventional | Initiator Pharma | ||
NCT04969666 | A Phase II, Repeat Single Oral Dose Study of IPED2015 in Healthy Male Subjects With Erectile Dysfunction | Phase 2 Interventional | Initiator Pharma |